Girolami A, Bertozzi I, de Marinis G Berti, Bonamigo E, Fabris F
Department of Medical and Surgical Sciences, University of Padua Medical School, Via Ospedale 105, Padua, Italy.
Hematology. 2011 Sep;16(5):308-12. doi: 10.1179/102453311X13085644680069.
Congenital FVII deficiency is usually subdivided into two forms: type I and type II. Type I is characterized by a concomitant deficiency of FVII activity and FVII antigen (true deficiency). Type II is characterized by a discrepancy between FVII activity which is always low and FVII antigen which may be normal, near normal, or reduced. Thromboplastins of different origins may show a discrepant behaviour towards type II FVII deficiencies. The abnormal factor VII present in these forms may, in fact show, different levels of activity, according to the thromboplastin used in the assay system. Typical of these variants is the Arg304Gln mutation (know as FVII Padua). In this variant, FVII level is low when rabbit brain thromboplastin is used, whereas the level is perfectly normal when ox-brain thromboplastin is employed. Intermediate levels are obtained if human placenta or human recombinant is used. Since ox-brain thromboplastin is very sensitive to activated FVII, the normal FVII levels obtained in FVII Padua could be due to abnormally high circulating levels of activated FVII. The purpose of the present paper was to investigate the level of activated FVII present in homozygotes and heterozygotes with FVII Padua. For comparison, a group of patients with type I or 'true' deficiency was also investigated. A group of 21 normal patients served as controls. The activated FVII level found in FVII Padua was 8·4 and 41·0 mU/ml for homozygotes and heterozygotes, respectively. The level found in homozygous true deficiency was unassayable, whereas that found in heterozygotes was 36·2 mU/ml. The level found in the control population was 64·9 mU/ml in agreement with other reports. The low levels of activated FVIIa found in homozygotes with FVII Padua indicate that the normal FVII activity found with ox-brain thromboplastin cannot be attributed to higher than normal circulating levels of FVIIa.
先天性FVII缺乏症通常分为两种类型:I型和II型。I型的特征是FVII活性和FVII抗原同时缺乏(真性缺乏)。II型的特征是FVII活性始终较低,而FVII抗原可能正常、接近正常或降低,两者之间存在差异。不同来源的凝血活酶对II型FVII缺乏症可能表现出不同的反应。这些类型中存在的异常FVII因子,实际上根据检测系统中使用的凝血活酶不同,可能表现出不同水平的活性。这些变异体的典型代表是Arg304Gln突变(称为FVII帕多瓦)。在这种变异体中,使用兔脑凝血活酶时FVII水平较低,而使用牛脑凝血活酶时水平完全正常。如果使用人胎盘或重组人凝血活酶,则会得到中间水平。由于牛脑凝血活酶对活化的FVII非常敏感,在FVII帕多瓦中获得的正常FVII水平可能是由于循环中活化FVII的异常高水平所致。本文的目的是研究FVII帕多瓦纯合子和杂合子中活化FVII的水平。为了进行比较,还研究了一组I型或“真性”缺乏症患者。一组21名正常患者作为对照。FVII帕多瓦纯合子和杂合子中活化FVII水平分别为8.4和41.0 mU/ml。纯合子真性缺乏症中发现的水平无法检测,而杂合子中发现的水平为36.2 mU/ml。对照人群中发现的水平为64.9 mU/ml,与其他报告一致。FVII帕多瓦纯合子中发现的低水平活化FVIIa表明,使用牛脑凝血活酶时发现的正常FVII活性不能归因于高于正常水平的循环FVIIa。